In the ever-evolving world of wellness, it’s no surprise that intravenous (IV) therapies have surged in popularity. Among these, NAD (nicotinamide adenine dinucleotide) IV drips have become the ...

A team developed an open-source model that simulates brain metabolism across neurons, glial cells and blood flow. It ...

By incorporating healthspan science into clinical practice, some doctors are navigating a gray area between mainstream ...

The interest in longevity and anti-aging, even among relatively young people, will not wane. More and more folks are turning their focus to diets, exercise and of course, supplements in an effort ...

Clene (NASDAQ: CLNN) , a late clinical-stage biopharmaceutical company, reported a full-year 2024 net loss of $39.4 million, or $5.67 per share, comp ...

Model allowed researchers to better understand the complex molecular mechanisms that determine the robustness, flexibility, ...

EQS-News: Clene Inc. / Key word (s): Financial Clene to Participate in Jones Las Vegas Technology and Innovation Conference on April 8-9, 2025 25.03.2025 / 13:37 CET/CEST The issuer is solely ...

The models suggested that administration of a drug that blocked the formation of NAD + —called a mitochondrial complex I blockade—would improve TSW symptoms. In a pilot study to further assess this ...